Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart and Detemir Protocol for ER Hyperglycemia
NCT00591227Phase 4Completed
- Sponsor
- Rush University Medical Center
- Start
- May 2008
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Hospital Length of Stay. Started May 2008; status: completed.
02
Drugs
human insulininsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00591227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591227.